Characterization and dissolution study of chitosan freeze-dried systems for drug controlled Release

Molecules

Volumn 14, Issue 11, 2009, Pages 4370-4386

  Ruiz Caro, Roberto ^a   Veiga Ochoa, María Dolores ^a,b  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^b Unidad de Biotransformaciones Industriales   (Spain)

Author keywords

Caffeine; Chitosan; Controlled release; Freeze dried systems; Swelling and dissolution behaviour

Indexed keywords

CAFFEINE; CHITOSAN;

ARTICLE; CHEMISTRY; DIFFERENTIAL SCANNING CALORIMETRY; FREEZE DRYING; METHODOLOGY; PH; X RAY DIFFRACTION;

CAFFEINE; CALORIMETRY, DIFFERENTIAL SCANNING; CHEMISTRY, PHARMACEUTICAL; CHITOSAN; FREEZE DRYING; HYDROGEN-ION CONCENTRATION; X-RAY DIFFRACTION;

EID: 73349142010     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules14114370     Document Type: Article

References (39)

1. Streubel, A.; Siepmann, J.; Bodmeier, R. Gastroretentive drug delivery systems. Expert Opin. Drug Deliv. 2006, 3, 217-233.
2. Illum, L. Chitosan and its use as a pharmaceutical excipient. Pharm. Res. 1998, 15, 1326-1331.
3. Tomihata, K.; Ikada, Y. In vitro and in vivo degradation of films of chitin and its deacetylated derivatives. Biomaterials 1997, 18, 567-575.
4. Felt, O.; Buri, P.; Gurny, R. Chitosan: A unique polysaccharide for drug delivery. Drug Dev. Ind. Pharm. 1998, 24, 979-993.
5. Agnihotri, S. A.; Mallikarjuna, N. N.; Aminabhavi, T. M. Recent advances on chitosan-based micro-and nanoparticles in drug delivery. J. Control. Rel. 2004, 100, 5-28.
6. Sinha, V. R.; Singla, A. K.; Wadhawan, S.; Kaushik, R.; Kumria, R.; Bansal, K.; Dhawan S. Chitosan microspheres as a potential carrier for drugs. Int. J. Pharm. 2004, 274, 1-33.
7. Singla, A. K.; Chawla, M. Chitosan: some pharmaceutical and biological aspects-an update. J. Pharm. Pharmacol. 2001, 53, 1047-1067.
8. Amiji, M. M.; Patel, V. R. Preparation and characterization of freeze-dried chitosan-poly (ethylene oxide) hydrogels for site-specific antibiotic delivery in the stomach. Pharm. Res. 1996, 13, 588-593.
9. Knapczyk, J.; Krowczynski, L.; Krzek, J.; Brzeski, M.; Nurnberg, E.; Schenk, D.; Struszczyk, H. Requirements of chitosan for pharmaceutical and biomedical applications. In Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Applications; Skjak-Braek, G., Anthonsen, T., Sandford, P., Eds.; Elsevier: London, UK, 1989; pp. 657-664.
10. Sandford, P. A. Chitosan: commercial uses and potential applications. In Chitin and Chitosan-Sources, Chemistry, Biochemistry, Physical Properties and Applications; Skjak-Braek, G., Anthonsen, T., Sandford, P., Eds.; Elsevier: London, UK, 1989; pp. 51-69.
11. Errington, N.; Harding, S. E.; Varum, K. M.; Illum, L. Hydrodynamic characterization of chitosans varying in degree of acetylation. Int. J. Biol. Macromol. 1993, 15, 113-117.
12. Fukuda, H. Polyelectrolyte complexes of chitosan with sodium carboxymethylcellulose. Bull. Chem. Soc. Jpn. 1980, 53, 837-840.
13. Fukuda, H.; Kikuchi, Y. Polyelectrolyte complexes of chitosan with sodium carboxymethyldextran. Bull. Chem. Soc. Jpn. 1978, 51, 1142-1144.
14. Ubaidulla, U.; Khar, R. K.; Ahmad, F. J.; Sultana, Y.; Panda, A. K. Development and characterization of chitosan succinate microspheres for the improved oral bioavailability of insulin. J. Pharm. Sci. 2007, 96, 3010-3023.
15. Hassan, E. E.; Gallo, J. M. A simple rheological method for the in vitro assessment of mucinpolymer bioadhesive bond strength. Pharm. Res. 1990, 7, 491-495.
16. Luesßen, H. L.; Lehr, C. M.; Rentel, C. O.; Noach, A. B. J.; de Boer, A. G.; Verhoef, J. C.; Junginger, H. E. Bioadhesive polymers for the peroral delivery of peptide drugs. J. Control. Rel. 1994, 29, 329-338.
17. Luesßen, H. L.; de Leeuw, B. J.; Langemeÿer, M. W.; de Boer, A. G.; Verhoef, J. C.; Junginger, H. E. Mucoadhesive polymers in peroral peptide drug delivery. VI. Carbomer and chitosan improve the intestinal absorption of the peptide drug buserelin in vivo. Pharm. Res. 1996, 13, 1668-1672.
18. Luessßen, H. L.; Rentel, C. O.; Kotzé, A. F.; Lehr, C. M.; de Boer, A. G.; Verhoef, J. C.; Junginger, H. E. Mucoadhesive polymers in peroral peptide drug delivery. IV. Polycarbophil and chitosan are potent enhancers of peptide transport across intestinal mucosae in vitro. J. Control. Rel. 1997, 45, 15-23.
19. Remuñán-López, C.; Portero, A.; Vila-Jato, J. L.; Alonso, M. J. Design and evaluation of chitosan/ethylcellulose mucoadhesive bilayered devices for buccal drug delivery. J. Control. Rel. 1998, 55, 143-152.
20. Lee, M. H.; Chun, M. K.; Choi, H. K. Preparation of Carbopol/chitosan interpolymer complex as a controlled release tablet matrix: Effect of complex formation medium on drug release characteristics. Arch. Pharm. Res. 2008, 31, 932-937.
21. Aiedeh, K. M.; Taha, M. O.; Al-Hiari, Y.; Bustanji, Y.; Alkhatib, H. S. Effect of ionic crosslinking on the drug release properties of chitosan diacetate matrices. J. Pharm. Sci. 2007, 96, 38-43.
22. Zerrouk, N.; Mennini, N.; Maestrelli, F.; Chemtob, C.; Mura, P. Comparison of the effect of chitosan and polyvinylpyrrolidone on dissolution properties and analgesic effect of naproxen. Eur. J. Pharm. Biopharm. 2004, 57, 93-99.
23. Park, K. M.; Bae, J. W.; Joung, Y. K.; Shin, J. W.; Park, K. D. Nanoaggregate of thermosensitive chitosan-Pluronic for sustained release of hydrophobic drug. Colloids Surf. B. Biointerfaces 2008, 63, 1-6.
24. Lim Soo, P.; Cho, J.; Grant, J.; Ho, E.; Piquette-Miller, M.; Allen, C. Drug release mechanism of paclitaxel from a chitosan-lipid implant system: Effect of swelling, degradation and morphology. Eur. J. Pharm. Biopharm. 2008, 69, 149-157.
25. McConnell, E. L.; Murdan, S.; Basit, A. W. An Investigation into the Digestion of Chitosan (Noncrosslinked and Crosslinked) by Human Colonic Bacteria. J. Pharm. Sci. 2008, 97, 3820-3829.
26. Oosegi, T.; Onishi, H.; Machida, Y. Novel preparation of enteric-coated chitosan-prednisolone conjugate microspheres and in vitro evaluation of their potential as a colonic delivery system. Eur. J. Pharm. Biopharm. 2008, 68, 260-267.
27. Levis, S. R.; Deasy, P. B. Use of coated microtubular halloysite for the sustained release of diltiazem hydrochloride and propranolol hydrochloride. Int. J. Pharm. 2003, 253, 145-157.
28. Lin, C. L.; Chiu, W. Y.; Lee, C. F. Preparation of thermoresponsive core-shell copolymer latex with potential use in drug targeting. J. Colloid Interface Sci. 2005, 290, 397-405.
29. Huang, R. G.; Schwartz, J. B.; Ofner, C. M., III. Microencapsulation of chlorpheniramine maleate-resin particles with crosslinked chitosan for sustained release. Pharm. Dev. Technol. 1999, 4, 107-115.
30. nd Edition; Moffat, A. C., Ed.; The Pharmaceutical Press: London, UK, 1986; pp. 420-422.
31. Villa, L. F. Medimecum, 9th ed.; Adis International: Madrid, Spain, 2004; p. 675.
32. Wu, N.; Wang, L. S.; Tan, D. C.; Moochhala, S. M.; Yang, Y. Y. Mathematical modelling and in vitro study of controlled drug release via a highly swellable and dissoluble polymer matrix: polyethylene oxide with high molecular weights. J. Control. Rel. 2005, 102, 569-581.
33. Ainaoui, A.; Siepmann, J.; Bodmeier, R.; Vergnaud, J. M. Calculation of the dimensions of dosage forms with release controlled by diffusion for in vivo use. Eur. J. Pharm. Biopharm. 2001, 51, 17-24.
34. Hu, Z.; Mawatari, S.; Shimokawa, T.; Kimura, G.; Yoshikawa, Y.; Shibata, N.; Takada, K. Colon delivery efficiencies of intestinal pressure-controlled colon delivery capsules prepared by a coating machine in human subjects. J. Pharm. Pharmacol. 2000, 52, 1187-1193.
35. Lagarde, D.; Batejat, D.; Sicard, B.; Trocherie, S.; Chassard, D.; Enslen, M.; Chauffard, F. Slowrelease caffeine: a new response to the effects of a limited sleep deprivation. Sleep 2000, 23, 651-661.
36. De Lima, M. S.; Freire, M. S; Fonseca, J. L.; Pereira, M. R. Chitosan membranes modified by contact with poly (acrylic acid). Carbohydr. Res. 2009, 344, 1709-1715.
37. Synytsya, A.; Synytsya, A.; Blafková, P.; Ederová, J.; Spevacek, J.; Slepicka, P.; Král, V.; Volka, K. pH-controlled self-assembling of meso-tetrakis (4-sulfonatophenyl) porphyrin-chitosan complexes. Biomacromolecules 2009, 11, 1067-1076.
38. Real Farmacopea Española (RFE), 3rd ed.; Agencia Española de Medicamentos y Productos Sanitarios (Ministerio de Sanidad y Consumo) : Madrid, Spain, 2005; p. 482.
39. Haupt, S.; Zioni, T.; Gati, I.; Kleinstern, J.; Rubinstein, A. Luminal delivery and dosing considerations of local celecoxib administration to colorectal cancer. Eur. J. Pharm. Sci. 2006, 28, 204-211. © 2009